Also, the prostate-specific antigen (PSA) value as a tumor marker requires a treatment interval of about 3 months to reach prognostic significance and is unreliable to reveal treatment response, as is the case with other serum derived markers such as lactate dehydrogenase and alkaline phosphatase [5, 9–12]. This evidence concerns the gene KLK3 and neoplasm.